RSS

Lilly

German biotechnology company, Topas Therapeutics, has signed a multi-year agreement with Eli Lilly and Company, which will see the companies collaborate to generate drug candidates in the field of antigen specific tolerance induction. Read more

News

A quick review of some recent treatment approvals, clinical studies and general news in curing diseases, affecting patients from top to bottom. Read more

News

Global healthcare company Lilly has announced the results of a phase 3 clinical trial, designed to test the efficacy of a drug to slow the effects of Alzheimer’s. Read more

News

GSK, Novartis and Lilly have recently aligned in an effort to set out a new minimum standard or performance from their respective companies according to eyeforpharma Read more

News